Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.
de Salazar A, Dietz J, di Maio VC, Vermehren J, Paolucci S, Müllhaupt B, Coppola N, Cabezas J, Stauber RE, Puoti M, Arenas Ruiz Tapiador JI, Graf C, Aragri M, Jimenez M, Callegaro A, Pascasio Acevedo JM, Macias Rodriguez MA, Rosales Zabal JM, Micheli V, Garcia Del Toro M, Téllez F, García F, Sarrazin C, Ceccherini-Silberstein F; GEHEP-004 cohort, the European HCV Resistance Study Group and the HCV Virology Italian Resistance Network (VIRONET C). de Salazar A, et al. J Antimicrob Chemother. 2020 Nov 1;75(11):3349-3358. doi: 10.1093/jac/dkaa304. J Antimicrob Chemother. 2020. PMID: 32772078
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
Dietz J, Spengler U, Müllhaupt B, Schulze Zur Wiesch J, Piecha F, Mauss S, Seegers B, Hinrichsen H, Antoni C, Wietzke-Braun P, Peiffer KH, Berger A, Matschenz K, Buggisch P, Backhus J, Zizer E, Boettler T, Neumann-Haefelin C, Semela D, Stauber R, Berg T, Berg C, Zeuzem S, Vermehren J, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Clin Gastroenterol Hepatol. 2021 Jan;19(1):195-198.e2. doi: 10.1016/j.cgh.2019.10.051. Epub 2019 Nov 6. Clin Gastroenterol Hepatol. 2021. PMID: 31706062
Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease.
Wethkamp N, Nordlohne EM, Meister V, Helwig U, Respondek M. Wethkamp N, et al. Among authors: meister v. Mod Pathol. 2018 Mar;31(3):527-538. doi: 10.1038/modpathol.2017.149. Epub 2017 Dec 1. Mod Pathol. 2018. PMID: 29192648
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.
Dietz J, Susser S, Vermehren J, Peiffer KH, Grammatikos G, Berger A, Ferenci P, Buti M, Müllhaupt B, Hunyady B, Hinrichsen H, Mauss S, Petersen J, Buggisch P, Felten G, Hüppe D, Knecht G, Lutz T, Schott E, Berg C, Spengler U, von Hahn T, Berg T, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Gastroenterology. 2018 Mar;154(4):976-988.e4. doi: 10.1053/j.gastro.2017.11.007. Epub 2017 Nov 13. Gastroenterology. 2018. PMID: 29146520
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.
Neumann JE, Wefers AK, Lambo S, Bianchi E, Bockstaller M, Dorostkar MM, Meister V, Schindler P, Korshunov A, von Hoff K, Nowak J, Warmuth-Metz M, Schneider MR, Renner-Müller I, Merk DJ, Shakarami M, Sharma T, Chavez L, Glass R, Chan JA, Taketo MM, Neumann P, Kool M, Schüller U. Neumann JE, et al. Among authors: meister v. Nat Med. 2017 Oct;23(10):1191-1202. doi: 10.1038/nm.4402. Epub 2017 Sep 11. Nat Med. 2017. PMID: 28892064
Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.
Kucharzik T, Wittig BM, Helwig U, Börner N, Rössler A, Rath S, Maaser C; TRUST study group. Kucharzik T, et al. Clin Gastroenterol Hepatol. 2017 Apr;15(4):535-542.e2. doi: 10.1016/j.cgh.2016.10.040. Epub 2016 Nov 14. Clin Gastroenterol Hepatol. 2017. PMID: 27856365
[Improvement of cost allocation in gastroenterology by introduction of a novel service catalogue covering the complete spectrum of endoscopic procedures].
Rathmayer M, Scheffer H, Braun M, Heinlein W, Akoglu B, Brechmann T, Gölder SK, Lankisch T, Messmann H, Schneider A, Wagner M, Fleßa S, Meier A, Lewerenz B, Gossner L, Faiss S, Toermer T, Werner T, Wilke MH, Lerch MM, Schepp W; DRG-Arbeitsgruppe und das Zeiterfassungsprojekt der DGVS (Autoren im Anhang). Rathmayer M, et al. Z Gastroenterol. 2015 Mar;53(3):183-98. doi: 10.1055/s-0034-1399199. Epub 2015 Mar 16. Z Gastroenterol. 2015. PMID: 25775168 German.
Chelidonium majus: a rare reason for severe hepatotoxic reaction.
Greving I, Meister V, Monnerjahn C, Müller KM, May B. Greving I, et al. Among authors: meister v. Pharmacoepidemiol Drug Saf. 1998 Aug;7 Suppl 1:S66-9. doi: 10.1002/(sici)1099-1557(199808)7:1+3.3.co;2-7. Pharmacoepidemiol Drug Saf. 1998. PMID: 15073964 No abstract available.
Effects of ginger on gastroduodenal motility.
Micklefield GH, Redeker Y, Meister V, Jung O, Greving I, May B. Micklefield GH, et al. Among authors: meister v. Int J Clin Pharmacol Ther. 1999 Jul;37(7):341-6. Int J Clin Pharmacol Ther. 1999. PMID: 10442508 Clinical Trial.
Anorectal functions in patients with spinal cord injury.
Greving I, Tegenthoff M, Nedjat S, Orth G, Bötel U, Meister V, Micklefield G, May B, Enck P. Greving I, et al. Among authors: meister v. Neurogastroenterol Motil. 1998 Dec;10(6):509-15. doi: 10.1046/j.1365-2982.1998.00124.x. Neurogastroenterol Motil. 1998. PMID: 10050256
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback